HIF1A and cancer: Despite the recognition of HIF-1α as a crucial regulator of ESCC, the precise molecular mechanisms governing its regulation in cancer cells remain unclear, and the potential for targeting the ubiquitin degradation of HIF-1α in clinical contexts requires further exploration.